Raywatt

Raywatt (레이와트) is a South Korean medtech startup founded in 2019 as a Sejong University faculty spin-off. It develops intravascular imaging systems based on optical coherence tomography (OCT) with AI-based diagnostic software for coronary intervention, and is extending the technology toward cerebrovascular imaging. Its Series A investors included Korea Investment Partners, IBK and SBI Investment.

  • Series A
  • AI/ML
  • Diagnostics
  • Healthtech
  • Medtech
  • Healthcare & Life Sciences

1

Round

1

Industry

5

Tags

Nov 11, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 11, 2026

    KRW 9.7M

    Series B

    • Hyundai Technology Investment
    • Intervest
    • Life Asset Management (라이프자산운용)

    Article coming soon.

Pricing

Research Raywatt — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Raywatt is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational